1ARK

LS ARK Innovation Tracker ETP Securities

ETFs & Funds · USD · LSE

1ARKETFT212

Price

$4.125

+2.75%

Cap

Earnings

30d Trend

+4.6%

1ARK
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

38% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level59
Momentum70
Technical55
Fund Quality47
Cost Efficiency40

Raw weighted: 51×Macro 0.99 (1%)=50

RISK

59/100
90d Volatility
38.2%High
ATR %
2.0%Normal
Max Drawdown (1Y)
-30.5%Volatile

MOMENTUM

70/100
12-1M Momentum
+33.0%Strong uptrend
6-1M Momentum
-5.6%Negative
1M Return
+3.0%Stable

TECHNICAL

55/100
RSI (14)
55.2Neutral
Price vs SMA200
-0.4%Flat
MACD
-0.01Bearish momentum
Bollinger Band
64%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.044Noisy/choppy

FUND QUALITY

47/100
Replication
SyntheticUses swaps (counterparty risk)
Holdings
36 positionsConcentrated
Domicile
JerseyCheck tax treaty

COST EFFICIENCY

40/100
Expense Ratio
0.75%Moderate
Fund Size (AUM)
$17MMicro (closure risk)

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months47
3-12 months54
1-5+ years49

Medium-term outlook is neutral — no clear directional thesis

BRAIN47'S ASSESSMENT

I rate LS ARK Innovation Tracker ETP Securities at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 70/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+3.0%

3 MONTHS

+6.9%

12 MONTHS

+36.0%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Medium-term outlook is neutral — no clear directional thesis. Momentum (70) and Technical (55) are the primary strengths. I note that cost efficiency is the weakest area at 40/100 — this warrants monitoring. Historical volatility is moderate at 38%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 50/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.